“Design, Molecular Docking, Synthesis, and Pharmacological Evaluation of Nabumetone-Derived Oxadiazole and Thiadiazole Schiff Bases As Potential EGFR Inhibitors for NSCLC”. 2026. Al Mustansiriyah Journal of Pharmaceutical Sciences 25 (5): 973-91. https://doi.org/10.32947/ajps.v25i5.1318.